Published in Clin Chest Med on September 01, 2004
Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest (2010) 2.51
Autoimmune-featured interstitial lung disease: a distinct entity. Chest (2011) 2.20
BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Sci Transl Med (2013) 1.67
Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med (2012) 1.46
Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med (2009) 1.36
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther (2008) 1.08
COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis. Nat Genet (2015) 0.96
Interstitial lung disease in connective tissue disease--mechanisms and management. Nat Rev Rheumatol (2014) 0.83
Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest (2009) 0.83
Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases. Chest (2010) 0.81
Significance of myositis autoantibody in patients with idiopathic interstitial lung disease. Yonsei Med J (2015) 0.75
Aberrant expression of cytokine interleukin 9 along with interleukin 4 and interferon γ in connective tissue disease-associated interstitial lung disease: association with severity of pulmonary fibrosis. Arch Med Sci (2015) 0.75
Nonspecific interstitial pneumonia: clinical associations and outcomes. BMC Pulm Med (2014) 0.75
Reasons for coming to hospital after treatment for community-acquired pneumonia on an ambulatory basis. Can Respir J (2006) 0.75
Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study. Respir Med (2015) 0.75
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol (2009) 1.78
Concomitant sarcoidosis and a connective tissue disease: review of the clinical findings and postulations concerning their association. Respir Med (2013) 1.41
Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest (2009) 1.25
Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways. Arthritis Rheum (2007) 0.97
Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med (2005) 0.96
Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum (2007) 0.96
Pulmonary involvement in Sjögren syndrome. Clin Chest Med (2010) 0.94
Cost-utility of treatments for pulmonary arterial hypertension: a Markov state-transition decision analysis model. Clin Drug Investig (2009) 0.90
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival. Chest (2008) 0.90
Rationale for anticoagulant therapy of pulmonary fibrosis. Am J Respir Crit Care Med (2014) 0.86
Chronic dyspnea and severe obstruction after pneumonectomy: postpneumonectomy syndrome. Am J Med Sci (2008) 0.82
The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects. Pulm Med (2011) 0.81
Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum (2009) 0.80
Critical care challenges in the adult ECMO patient. Dimens Crit Care Nurs (2005) 0.78
Chronic obstructive pulmonary disease in geriatric critical care. Crit Care Clin (2003) 0.75